A Turning Point for Peptides? What RFK Jr.'s Announcement Could Mean for the Future of Wellness and Longevity Skytale Group FDA Peptide Reclassification 2026 Amanecia Health BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification 2026 predictions: historic FDA shift, plausible mechanisms, bespoke tx, RFK Jr., biotechs, state AGs, peptides, embryos The Niche